Past Medical History: DM2 (stopped medical treatment 1 year ago)  Social History: Patient denies tobacco/ETOH/illicit drug use  Physical Exam: at admission: General: awake and alert CV: RRR Lungs: CTA bilaterally Abdomen: soft, NT/ND, NABS Ext: RLE w/ dressing in place c/d/i  At discharge: VS: Tm 98.4  Tc 98.2  P 76  BP 131/62  RR 18  SaO2 97 RA Gen: NAD CV: RRR Pulm: CTA B/L Abd: soft, nt/nd wound: R foot TMA site: plantar aspect wound with w-d dressing; flap with cnetral necrosis (unknown depth), adaptic dressings placed   Pertinent Results: [**2191-11-19**] 08:35PM   GLUCOSE-218* UREA N-29* CREAT-0.9 SODIUM-140 POTASSIUM-3.8 CHLORIDE-108 TOTAL CO2-25 ANION GAP-11 [**2191-11-19**] 08:35PM   CALCIUM-8.2* PHOSPHATE-1.7* MAGNESIUM-1.6 [**2191-11-19**] 05:30PM   %HbA1c-15.0* [**2191-11-19**] 05:30PM URINE  HOURS-RANDOM CREAT-34 SODIUM-17 [**2191-11-19**] 05:30PM URINE  OSMOLAL-530 [**2191-11-19**] 05:27PM URINE  COLOR-Yellow APPEAR-Clear SP [**Last Name (un) 155**]-1.023 [**2191-11-19**] 05:27PM URINE  BLOOD-LG NITRITE-POS PROTEIN-NEG GLUCOSE-1000 KETONE-150 BILIRUBIN-NEG UROBILNGN-NEG PH-5.0 LEUK-TR [**2191-11-19**] 05:27PM URINE  RBC-[**5-2**]* WBC-[**1-26**] BACTERIA-MOD YEAST-NONE EPI-0-2 [**2191-11-19**] 02:30PM   GLUCOSE-491* LACTATE-1.6 NA+-138 K+-4.6 CL--98* TCO2-18* [**2191-11-19**] 02:15PM   GLUCOSE-544* UREA N-35* CREAT-1.2* SODIUM-135 POTASSIUM-4.6 CHLORIDE-96 TOTAL CO2-17* ANION GAP-27* [**2191-11-19**] 02:15PM   estGFR-Using this [**2191-11-19**] 02:15PM   ACETONE-LARGE OSMOLAL-325* [**2191-11-19**] 02:15PM   WBC-28.6* RBC-3.76* HGB-11.5* HCT-36.2 MCV-96 MCH-30.5 MCHC-31.7 RDW-12.5 [**2191-11-19**] 02:15PM   NEUTS-97.6* LYMPHS-1.5* MONOS-0.8* EOS-0.1 BASOS-0 [**2191-11-19**] 02:15PM   PLT COUNT-377 [**2191-11-19**] 02:15PM   PT-12.9 PTT-24.1 INR(PT)-1.1  Culture data: [**11-18**] blood: NG x2 [**11-18**] urine: E. coli 10,000-100,000 ORGANISMS/ML (pansensitive) [**11-19**] wound: 2+PMN, 3+GPR, 2+GNR, 2+GPC; cx MSSA [**11-21**] urine: NG [**11-28**]: cdiff: neg  [**11-18**] R foot XR: IMPRESSION: Marked osseous destruction about the second proximal phalanx and interphalangeal joint with marked overlying soft tissue swelling.
Recommend renal ultrasound for further evaluation of possible right hydronephrosis versus prominent extrarenal pelvis.
Recommend thyroid ultrasound for further evaluation of a right thyroid lesion.
Recommend non-emergent evaluation of the supraglottic airway to distinguish secretions from polyps.
[**11-24**] CT abd/pelvis: IMPRESSION 1.
She was afebrile with a white count to 32K.
Right foot film showed marked osseous destruction about the second priximal phalanx and interphalangeal joint with marked overlying soft tissue swelling.
OSH blood cx grew out Strep agalactiae  [**11-19**]: continued abx, trending WBC (22K) and fever curve (afebrile), glucose control; Cr trended down; urine cx showed pan-sensitive e coli.
blood cultures grew out MSSA - patient left on broad spectrum coverage.
The medicine team discussed the R atrial band with the TEE fellow, Dr. [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) **], and her attending - this is a normal variant that does not require further testing or follow up.
CTA showed a 2.6cm RUL nodule - recommend 2 month f/u; right hydronephrosis - recommend f/u; thyroid nodule - recomment f/u.
; recommend non-emergent evaluation of the supraglottic airway to distinguish secretions from polyps.
[**2114-11-21**] - WBC below 10, remained so for remainder of hospitalization; urine cx came back negative.
[**11-27**]: cardiac enzymes negative  [**11-28**]: PT rec rehab; Medicine consult recs: ** Obtain Primary care physician ** 1) nafcillin 10 days 2) pulm nodule - follow up in 2 months for repeat CT 3) R hydronephrosis - f/u with urology physician 4) DM2 - continue lantus, current regimen; f/u with PCP 5) HTN: metoprolol 12.5 [**Hospital1 **], lisinopril 2.5 Qdaily (titrate in rehab) 6) osteoporosis: calcium (1500mg daily divided in 3 doses) and vit D 800 U daily; consider fosamax  On [**11-29**], the patient was discharged to rehab stable, in good condition, with the following recommendations: - obtain a primary physician to follow up lung nodule, thyroid nodule, right kidney hydronephrosis, diabetesm osteoporosis, and high blood pressure - follow up with Dr. [**Last Name (STitle) 1391**] - follow up with podiatry She will complete a 2 week course of nafcillin.
Cholecalciferol (Vitamin D3) 400 unit Tablet Sig: Two (2) Tablet PO DAILY (Daily).
Discharge Disposition: Extended Care  Facility: [**Hospital3 7**] & Rehab Center - [**Hospital1 8**]  Discharge Diagnosis: DKA ARF (hypovolemic) osteomyelitis Thyroid Nodule - will need follow up Lung Nodule - will need follow up Right Hydronephrosis - will need follow up   Discharge Condition: good, stable condition   Discharge Instructions: If you develop fevers, chills, foul-smelling or purulunt drainage from your wound, new spreading redness or pain from your wound, shortess of breath, chest pain, or any other disturbing symtoms, please call the vascular surgery office of Dr. [**Last Name (STitle) 1391**] at [**Telephone/Fax (1) 1393**] or go to the emergency room.
Obtain a primary physician to follow up lung nodule, thyroid nodule, right kidney hydronephrosis, diabetesm osteoporosis, and high blood pressure    Completed by:[**2191-11-29**
